Article Sidebar

Submitted
Apr 21, 2021
Published
Apr 21, 2021
Download
PDF
Statistic
Read Counter : 50 Download : 25

Main Article Content

Abstract

Background


The concept of Essential medicines was pioneered by the WHO in 1977 to provide safe and effective treatment against the global burden of disease. Latest, 19thEML by WHO and 4th list of NLEM are published in 2015


Aims and Objectives


To study the factors affecting the change in profile of Essential medicine list.


Materials and Methods


The EML was accessed from the official website of WHO and the NLEM from Central Drugs Standard Control Organization website, downloaded and compared. A detailed analysis of 1st and latest EML was done in terms of System wise allocation, addition and deletion of medicines


Results


There is steady increase in number of Essential Medicines from 204 to 414 in latest EML of WHO when compared to first list. Maximum allocation of medicines  in WHO first list  is for Infectious disease (53/204,26%) followed by Cardiovascular diseases (25/204,12%),Central nervous system disorders (15/204,7%) whereas in latest version of EML by WHO maximum allocation of medicines is to Infectious diseases (135/414,33%) followed by antineoplastic medicines (47/414,11%), cardiovascular disorders (32/414,8%). Maximum increase in medicines is seen with following sub categories of diseases like Antineoplastic (47), Anti viral drugs (27), Anti tubercular drugs (17), Contraceptives (16), antidotes (15). Some of the medicines like Atorvastatin, Telmisartan, Glimepiride, Thiopentone, cetirizine etc are included in NLEM 2015 but not included in WHO-EML 2015


Conclusion


The study gives insight about the change in profile of medicines in essential medicine list over a period of time with respect to change in burden of disease, newer diseases , newer invention of safe and effective medicines

Keywords

WHO Essential medicine list NLEM Allocation

Article Details

How to Cite
Kavyashree AC, & Laxminarayana Kamath. (2021). Comparative analysis of first versus latest version of WHO essential medicine list. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(2), 224-231. https://doi.org/10.61096/ijrpp.v6.iss2.2017.224-231
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Health care of the community. In: Park K. Park’s textbook of Preventive and Social Medicine, ed. Jabalpur: M/s BanarsidasBhanot; 24, 2015, 927-929
  2. [2]. The selection of essential medicines. WHO Policy perspectives on Medicines. Geneva: World Health Organization; 2002
  3. [3]. WHO model list of essential medicines. 1, 1977. Available at http://www.who.int/medicines/publications/essentialmedicines/en/index.html. Accessed 2016
  4. [4]. WHO model list of essential medicines. 19, 2015. Available at http://www.who.int/medicines/publications/essentialmedicines/en/index.html. Accessed 2016
  5. [5]. National list of essential medicines of India 2015. Available at http://www.cdsco.nic.in. Accessed 2017
  6. [6]. WHO, “Revised Procedure for Updating WHO’s Model List of Essential Drugs”, 2001. Available at http://apps.who.int/gb/archive/pdf files/EB109/eeb1098.pdf?ua=1. Accessed from 2016
  7. [7]. WHO, “Essential Medicines List (EML) 2015 – Commented application Information to be included in an application for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines”, 2015.
  8. [8]. WHO, “Alliance for Health Policy and Systems Research; Medicines in Health Systems: Advancing access, affordability and appropriate use”, Flagship Report, 2014.
  9. [9]. Manikandan S, Gitanjali B. National list of essential medicines of India: The way forward. Journal of Postgraduate Medicine 58(1), 2012, 68-72.
  10. [10]. Sharma S, Kh R, Chaudhury RR. Attitude and opinion towards essential medicine formulary. Indian J Pharmacol 42, 2010, 1502.